Barinthus Biotherapeutics Plc (BRNS): $BRNS: NOw $2.50 ......... YEEEEeeeeeeha...

Next 10 Prev Next

Send PM Follow Ignore

Followers	1445
Posts	30532
Boards Moderated	35
Alias Born	12/10/2012

makinezmoney

Re: None

Wednesday, 07/16/2025 11:10:36 AM

Wednesday, July 16, 2025 11:10:36 AM

$BRNS: NOw $2.50 ......... YEEEEeeeeeehawwwwwwwwwwwwwwww

MONEYyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyy

Go baby gooooooooooooooooooooooooooooooooooooo

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent BRNS News

Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:03:12 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 11:43:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:32:43 AM
Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments • GlobeNewswire Inc. • 04/30/2026 11:30:00 AM
Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 04/30/2026 10:00:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 08:30:26 PM
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 04/13/2026 07:33:33 PM
Barinthus Bio Reports 2025 Results and Moves Forward with Planned Clywedog Merger • IH Market News • 03/13/2026 03:29:13 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/13/2026 12:13:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:03:44 PM
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments • GlobeNewswire Inc. • 03/13/2026 12:00:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/23/2026 11:29:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 11:02:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 09:09:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 01:05:05 PM
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease • GlobeNewswire Inc. • 12/10/2025 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 12:40:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 12:34:18 PM
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments • GlobeNewswire Inc. • 11/07/2025 12:30:00 PM
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics • PR Newswire (US) • 10/24/2025 03:00:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/30/2025 08:01:27 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/30/2025 12:20:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2025 12:16:58 PM
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases • GlobeNewswire Inc. • 09/30/2025 12:00:00 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/08/2025 08:20:09 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent BRNS News

More BRNS News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent BRNS News

Go Ad-Free